Gastric Emptying: Clinical Trials

5 trials for Gastric Emptying, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 22Completed 2

Follow Gastric Emptying: new trials by email Literature Review of Gastric Emptying trials Research Report on Gastric Emptying

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation
Daikenchuto (TU-100), Placebo - Functional Constipation, Gastric Emptying
Phase 1 / Phase 2CompletedTsumura USA452010-08-012013-01-14
Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit
Dexmedetomidine, Morphine, Placebo - Gastric Emptying, Healthy
Phase 1CompletedUniversity of Turku122010-03-012010-06-04
Scintigraphic Assessment Following Klean-Prep® or Moviprep®
Klean-Prep®, Moviprep® - Gastric Emptying, Healthy
Phase 1CompletedNorgine322006-09-012009-05-12
Use of Pyridostigmine for Constipation in Diabetics
Pyridostigmine, Placebo - Constipation, Diabetes Mellitus
Phase 1 / Phase 2CompletedMayo Clinic302006-05-012012-11-30
GLP-1 - Regulatory Mechanism of Postprandial Glycemia
Saline, Exendin(9-39)amide - Healthy Subjects, Gastric Emptying
Phase 1CompletedLudwig-Maximilians - University of Munich122004-10-012009-09-18

Narrower conditions

Constipation (2)  ·  Diabetes Mellitus (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

12,13-dihydro-N-methyl-6,11,13-trioxo-5H-benzo(4,5)cyclohepta(1,2-b)naphthalen-5,12-imine (1)  ·  Dexmedetomidine (1)  ·  Morphine (1)  ·  MoviPrep (1)  ·  Pyridostigmine Bromide (1)  ·  Sodium Chloride (1)  ·  dai-kenchu-to (1)  ·  exendin (9-39) (1)  ·  klean prep (1)

Sponsors

Ludwig-Maximilians - University of Munich (1)  ·  Mayo Clinic (1)  ·  Norgine (1)  ·  Tsumura USA (1)  ·  University of Turku (1)

Countries

United States (2)  ·  Finland (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Adil E. Bharucha, MBBS, MD (1)  ·  Joerg Schirra, Prof (1)  ·  Michael Camilleri, MD (1)  ·  Philip Evans, MB ChB MRCS (1)  ·  Timo Iirola, MD (1)

Results publications

PMID 22677718, PMID 23451764

NIH funding

P01DK068055 (1), UL1RR024150-01 (1)